GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Orange Peel Identified as Source of Crude Pectin, Prebiotic Compounds, and Antioxidants for Health and Sustainability

by GOAI
Share To

Recent studies have identified orange peel as a significant source of health-promoting compounds, including crude pectin, pectic oligosaccharides, and polyphenols. Researchers are examining the potential of these natural substances derived from agricultural waste to address issues related to waste management and sustainable food production. The findings suggest that orange peel may hold promise in contributing to both environmental sustainability and human health.

The study focuses on the bioactive properties of compounds found in orange peel, which is often discarded as waste during food processing. Crude pectin, a carbohydrate commonly used as a gelling agent in food products, has shown potential for various applications beyond its traditional use. Pectic oligosaccharides, derived from pectin breakdown, are being studied for their prebiotic effects on gut health. Additionally, polyphenols present in orange peel exhibit antioxidant properties that may support overall well-being. These discoveries highlight the possibility of repurposing agricultural byproducts like orange peel into valuable resources for health and sustainability initiatives.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top